DISEASE CANCELLING Trademark

Trademark Overview


On Friday, December 6, 2019, a trademark application was filed for DISEASE CANCELLING with the United States Patent and Trademark Office. The USPTO has given the DISEASE CANCELLING trademark a serial number of 88982289. The federal status of this trademark filing is REGISTERED as of Tuesday, September 7, 2021. This trademark is owned by Immuneering Corporation. The DISEASE CANCELLING trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery services provided through a computer software platform used for research and development in the field of drugs; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials via the internet; research and development of new products; medical and scientific research in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; platform as a service (PAAS) featuring computer software platforms using biology and chemistry analytics for determining drug candidates with reduced toxicity; platform as a service (PAAS) featuring computer software platforms for database mining, database analysis, database management and the application of artificial ...
disease cancelling

General Information


Serial Number88982289
Word MarkDISEASE CANCELLING
Filing DateFriday, December 6, 2019
Status700 - REGISTERED
Status DateTuesday, September 7, 2021
Registration Number6480120
Registration DateTuesday, September 7, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements


Disclaimer with Predetermined Text"DISEASE"
Goods and Servicesdrug discovery services provided through a computer software platform used for research and development in the field of drugs; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials via the internet; research and development of new products; medical and scientific research in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; platform as a service (PAAS) featuring computer software platforms using biology and chemistry analytics for determining drug candidates with reduced toxicity; platform as a service (PAAS) featuring computer software platforms for database mining, database analysis, database management and the application of artificial intelligence; consultancy in relation to the development and implementation of software and software based applications

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2019
Primary Code042
First Use Anywhere DateThursday, June 25, 2020
First Use In Commerce DateThursday, June 25, 2020

Trademark Owner History


Party NameImmuneering Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameImmuneering Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameImmuneering Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, September 7, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 3, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 2, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 7, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 24, 2021USE AMENDMENT FILED
Wednesday, July 7, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, June 23, 2021DIVISIONAL REQUEST RECEIVED
Wednesday, June 23, 2021TEAS REQUEST TO DIVIDE RECEIVED
Friday, July 2, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 24, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 23, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, January 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 20, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 19, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 19, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2020NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2020NON-FINAL ACTION WRITTEN
Friday, March 6, 2020ASSIGNED TO EXAMINER
Wednesday, December 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 10, 2019NEW APPLICATION ENTERED